IGFBP-1: An early predictor for insulin resistance in obese menopausal women;IGFBP-1: Marcador precoz de insulinorresistencia en mujeres obesas posmenopáusicas

Revista Argentina de Endocrinologia y Metabolismo

Volumn 38, Issue 4, 2001, Pages 191-197

  Belli, Susana ^a   Graffigna, M ^a   Oneto, A ^a  

^a NONE

Author keywords

IGFBP 1; Insulin resistance; Menopause

Indexed keywords

INSULIN; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; EARLY DIAGNOSIS; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MENOPAUSE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREDICTION;

EID: 0035741317     PISSN: 03264610     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hormonal and nutritional regulation of IGF-1 and its binding proteins
2. Insulin-like growth factors and their binding proteins biological actions
3. Insulin-like growth factor binding proteins in the human circulation: A review
4. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans
5. Regulation of the growth hormone-independent growth factor-binding protein in children
6. Prolonged exercise increases serum insulin-like growth factor binding proteins concentrations
7. Insulin-like growth factor binding protein 1 response to insulin during supression of endogenous insulin secretion
8. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes
9. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, dyslipidemia and atherosclerotic cardiovascular disease
10. Insulin like growth factor binding protein-1 as a marker for hyperinsulinemia in obese menopausal women
11. Insulin-like growth factor binding protein-1 as a predictor of glucose-estimulated hyperinsulinemia in prepubertal obese children
12. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women
13. Transdermal estrogen replacement therapy: Beneficial effects on hemostatic risk factors for cardiovascular disease
14. Impact of obesity on insulin action in volunteers with normal glucose tolerance: Demonstration of a threshold for the adverse effect of obesity
15. Insulin like growth factor binding protein-1 levels are strongly associated with insulin sensitivity and obesity in early pubertal children
16. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3 and IGF-1 in insulin dependent diabetes
17. The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment
18. Portal insulin concentrations rather than insulin sensitivity regulate serum sex bormone binding globulin and insulin like growth factor binding protein 1 in vivo
19. Obesity and insulin resistance